ArticleMolecular and clinical oncology2026

Impact of TAS-102 dose reduction on severe neutropenia and survival outcomes in patients with metastatic colorectal cancer and prior chemotherapy-induced neutropenia.

Chihiro Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.